Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04282343 · ClinicalTrials.gov registry record · NA
DISCO Application for the Improvement of Financial Outcomes in Patients With Hematologic Cancer
A NA study of Chronic Lymphocytic Leukemia and Plasma Cell Myeloma, sponsored by Barbara Ann Karmanos Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT04282343 is a NA study of Chronic Lymphocytic Leukemia and Plasma Cell Myeloma that has completed, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 25 participants, below the 182-participant average among 187 other Chronic Lymphocytic Leukemia trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04282343, a NA study of Chronic Lymphocytic Leukemia and Plasma Cell Myeloma, has completed, sponsored by Barbara Ann Karmanos Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This phase II trial studies how well the DIScussion of COst (DISCO) application (app) works in improving financial outcomes in patients with hematologic cancer. The DISCO app is an electronic, highly scalable and tailorable education and communication intervention that may help researchers learn more about improving how patients and oncologists discuss cancer treatment costs
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL The DISCO App
Study Locations (1)
Michigan
- Barbara Ann Karmanos Cancer Institute - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2020-02-25 |
| Est. Completion | 2022-10-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04282343
The ClinicalTrials.gov registry entry for NCT04282343 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 182-participant average among 187 other Chronic Lymphocytic Leukemia trials with a reported enrollment target (86% lower). The listed sponsor is Barbara Ann Karmanos Cancer Institute, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Chronic Lymphocytic Leukemia appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT04282343 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT04282343 about?
NCT04282343 is a clinical study titled "DISCO Application for the Improvement of Financial Outcomes in Patients With Hematologic Cancer". This phase II trial studies how well the DIScussion of COst (DISCO) application (app) works in improving financial outcomes in patients with hematologic cancer. The DISCO app is an electronic, highly scalable and tailorable education and communication intervention that may help researchers learn mor...
What is the current status of trial NCT04282343?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2020-02-25. Estimated completion is 2022-10-21.
What conditions does trial NCT04282343 study?
This clinical trial studies the following conditions: Chronic Lymphocytic Leukemia, Plasma Cell Myeloma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive.
What interventions are being tested in trial NCT04282343?
The interventions under investigation include: Usual Care (BEHAVIORAL), The DISCO App (BEHAVIORAL).
Who is sponsoring clinical trial NCT04282343?
This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04282343 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Lymphocytic Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
RECRUITING · NA
-
Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors
RECRUITING · NA
-
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
RECRUITING · NA
-
Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency
ACTIVE NOT RECRUITING · NA
-
Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members
ACTIVE NOT RECRUITING · NA
-
HEALTH4CLL2: A Randomized Waitlist Control Trial of Behavioral Interventions in Patients With Chronic Lymphocytic Leukemia
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.